What Conditions does Filgrastim-Aafi 480 Mcg/0.8 Ml Subcutaneous Syringe Treat?

  • severe chronic decrease of neutrophils in the blood
  • decrease of neutrophils in the blood from cancer chemotherapy
  • decrease in neutrophils caused by leukemia treatment
  • congenital deficiency of neutrophils
  • a white blood cell
  • improve stem cell recovery
  • prevent decreased white blood cell count from cancer chemotherapy
  • periodic decrease in neutrophils
  • decrease in neutrophils of unknown cause
  • neutrophils decreased by medication
  • decrease in white blood cells from AIDS
  • bone marrow graft acceptance
  • myelodysplastic syndrome
  • a bone marrow disorder
  • bone marrow failure from acute radiation toxicity

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.